Multitarget Pharmacotherapeutic Strategies for Metabolic Syndrome and Related Disorders: Perspectives on Personalized Medicine Using a Pharmacology Network Approach
- Authors: Samah M. Elaidy1, Fatma S. Samman2, Samar Imbaby3
-
View Affiliations Hide Affiliations1 Department of Clinical Pharmacology, Faculty of Medicine, Suez Canal University, 41522 Ismailia, Egypt 2 Department of Clinical Pharmacology, Faculty of Medicine, Suez Canal University, 41522 Ismailia, Egypt 3 Department of Clinical Pharmacology, Faculty of Medicine, Suez Canal University, 41522 Ismailia, Egypt
- Source: Metabolic Syndrome: A Comprehensive Update with New Insights , pp 217-236
- Publication Date: January 2025
- Language: English
Multitarget Pharmacotherapeutic Strategies for Metabolic Syndrome and Related Disorders: Perspectives on Personalized Medicine Using a Pharmacology Network Approach, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9789815322132/chapter-12-1.gif
One of the most common metabolic illnesses worldwide is the MetS. In the MetS and its related disorders, rationalized and evidence-based pharmacotherapeutic strategies are corner stones in the mitigation of polypharmacy. The pharmacology network approach and enhanced bioinformatics tools related to the epigenetic, genomic, transcriptomics, proteomic, and metabolomic levels are considered useful bench-side tools for the exploration of molecular preventive and therapeutic multitargets. Molecular multitarget therapy is regarded as a novel pharmacological strategy that forms the foundation of personalized and precision medicine. That will decrease the socioeconomic burden and will improve the health-related quality of life.
-
From This Site
/content/books/9789815322132.chapter-12dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
